Month: September 2025

Novartis to acquire Tourmaline Bio, complementing cardiovascular pipeline with pacibekitug for the treatment of atherosclerotic cardiovascular disease (ASCVD)

  Tourmaline Bio is a clinical-stage biopharmaceutical company developing pacibekitug, an anti-IL-6 mAb, as a treatment option for atherosclerotic cardiovascular...

Amgen and Kyowa Kirin Announce Top-Line Results From Rocatinlimab Phase 3 ASCEND Long-Term Extension Study in Adults With Moderate to Severe Atopic Dermatitis

THOUSAND OAKS, Calif. and TOKYO, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Amgen (NASDAQ:AMGN) and Kyowa Kirin Co., Ltd. (TSE:4151) today...

Maya and Duránd’s Superintelligence Human-Enhancement Technology Company, Labs, Raises $22.5 Million Series Seed Funding at a $10 Billion Valuation to Power its 7 Labs — including Yuhmmy App, YuhmmyAI featuring Social-Taste AI Models (STAMs) and Social-Taste Agents (STAGs) and Yuhmmy AR/VR

error: Content is protected !!